Search results for "kidney transplantation."

showing 10 items of 148 documents

Lipoprotein a) levels in end-stage renal failure and renal transplantation

1993

Some previous studies have documented an increase in lipoprotein (a) [Lp(a)] levels in renal diseases. Here, we report data in subjects with end-stage renal failure treated with hemodialysis (HD) or with continuous ambulatory peritoneal dialysis (CAPD) and in renal transplant recipients (RTR), compared with a group of normolipidemic controls (C). Lp(a) levels were significantly increased in HD and CAPD patients in comparison with C, while they were only slightly increased in RTR. Both HD and CAPD patients showed Lp(a) levels higher than in RTR, but no difference was found between the subjects of the two dialysis procedures. The prevalence of Lp(a) levels > 25 mg/dl was significantly higher …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentUrologyurologic and male genital diseasesNephropathyPeritoneal dialysisPeritoneal Dialysis Continuous AmbulatoryRenal DialysisRisk FactorsHumansMedicineAgedKidneybiologybusiness.industryContinuous ambulatory peritoneal dialysisLipoprotein(a)Middle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationmedicine.anatomical_structureCardiovascular Diseasesbiology.proteinKidney Failure ChronicFemaleHemodialysisbusinessLipoprotein(a)Lipoprotein
researchProduct

Dialysis and Kidney Transplantation: Similarities and Differences in the Psychological Aspects of Noncompliance

2006

Abstract Background Dialysis and kidney transplantation represent two effective strategies in treating chronic uremia, albeit with different results. Our study compared the psychological aspects of two categories of patients: patients who faced kidney transplantation and have been on dialysis, and noncompliant patients treated with these therapies. Materials and Methods On 170 patients (120 hemodialysis and 50 peritoneal dialysis) we used a personality analysis (MMPI2) and the COPE, which assessed the ability of patients to cope under certain conditions that can be perceived as stressful or, in any case, unusual. The screening succeeded in 11 cases among the first group and 9 in the second.…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentmedia_common.quotation_subjectPsychological interventionDiseasePeritoneal dialysisTreatment RefusalMMPIRenal DialysisAdaptation PsychologicalmedicineHumansPersonalityIntensive care medicineKidney transplantationDialysisAgedmedia_commonSettore MED/14 - NefrologiaPsychological TestsTransplantationMarital Statusbusiness.industryDialysis kidney transplantationMiddle Agedmedicine.diseaseKidney TransplantationTransplantationFemaleSurgeryHemodialysisbusinessPeritoneal DialysisStress PsychologicalTransplantation Proceedings
researchProduct

Mesh or no mesh: a hamletic dilemma to prevent Renal Allograft Compartment Syndrome (RACS)

2014

Tension-free muscle closure is essential in kidney transplantation, both in adult and pediatric patients. Tight muscle closure may lead to renal allograft compartment syndrome either due to compression of the renal parenchyma or due to kinking of the renal vessels. It may also cause kinking of the transplant kidney ureter, wound dehiscence and incisional hernia. Many techniques have been proposed in an attempt to achieve tension-free closure. There is a wrong belief among surgeons that using prosthetic mesh may increase the incidence of infective complications in these immunosuppressed patients. Also, there is fear that one is not able to monitor the renal graft by ultrasound and perform bi…

AdultRenal Allograft Compartment syndrome (RACS)Evidence-Based MedicineAbdominal WallSuture TechniquesPost transplant incisional herniaRenal transplantationSurgical MeshCompartment SyndromesKidney TransplantationAbdominal mesh closureSettore MED/18 - Chirurgia GeneraleTreatment OutcomeHumansChildPolytetrafluoroethylene
researchProduct

Double Endocrine Neoplasia in a Renal Transplant Recipient: Case Report and Review of the Literature

2011

Abstract Introduction The incidence of cancer compared for age groups is 3–4 times higher in transplant recipients than the general population. The increased risk is related to immunosuppressive therapy as well as the use of increasingly older donors and recipients. Although cardiovascular disease with a functioning transplant is the leading cause of death (47%), cancer mortality is significant especially among older patients. However, the most frequent posttransplantation cancers relate to hemolymphopoietic organs and skin, whereas the occurrence of solid tumors elsewhere is rare. Herein we have described a rare case of synchronous double malignancy of endocrine organs (thyroid-adrenal) in…

Adultmedicine.medical_specialtyBiopsymedicine.medical_treatmentAdrenal neoplasmSettore MED/08 - Anatomia PatologicaNephrectomyEndocrine neoplasia renal transplant recipientAdrenocortical CarcinomamedicineAdjuvant therapyHumansAdrenocortical carcinomaThyroid NeoplasmsMultiple endocrine neoplasiaThyroid cancerNeoplasm StagingTransplantationOxyphil Cellsbusiness.industryCarcinomaGraft SurvivalMultiple Endocrine NeoplasiaThyroidectomyAdrenalectomyMycophenolic Acidmedicine.diseaseKidney TransplantationAdrenal Cortex NeoplasmsCarcinoma PapillaryNephrectomySurgeryTransplantationSettore MED/18 - Chirurgia GeneraleTreatment OutcomeThyroid Cancer PapillaryCyclosporineThyroidectomyKidney Failure ChronicLymph Node ExcisionDrug Therapy CombinationFemaleSteroidsSurgeryTomography X-Ray ComputedbusinessImmunosuppressive AgentsTransplantation Proceedings
researchProduct

Improved short-term outcomes of kidney transplants in controlled donation after the circulatory determination of death with the use of normothermic r…

2021

Normothermic Regional Perfusion (NRP) allows the in situ perfusion of organs with oxygenated blood in donation after the circulatory determination of death (DCDD). We aimed at evaluating the impact of NRP on the short-term outcomes of kidney transplants in controlled DCDD (cDCDD). This is a multicenter, nationwide, retrospective study comparing cDCDD kidneys obtained with NRP versus the standard rapid recovery (RR) technique. During 2012-2018, 2,302 cDCDD adult kidney transplants were performed in Spain using NRP (n=865) or RR (n=1,437). The study groups differed in donor and recipient age, warm and cold ischemic time and use of ex situ machine perfusion. Transplants in the NRP group were m…

Adultmedicine.medical_specialtyTissue and Organ Procurementdonors and donationdelayed graft function (DGF)graft survivalnephrologyUrologykidney transplantationorgan procurement and allocationRegional perfusion030230 surgery03 medical and health sciences0302 clinical medicineHumansImmunology and AllergyMedicinePharmacology (medical)Retrospective StudiesTransplantationKidneyMachine perfusionorgan perfusion and preservationbusiness.industryGraft SurvivalRetrospective cohort studyOrgan PreservationKidney TransplantationTissue DonorspracticeDelayed Graft FunctionDeathPerfusionmedicine.anatomical_structureclinical researchDonationPropensity score matchingCirculatory systembusinessdonation after circulatory death (DCD)
researchProduct

CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo.

1996

In the present report the immunosuppressive effects of the murine anti-human CD4 monoclonal antibody (mAb) VIT4 on human alloimmune response in vitro were analyzed. Moreover, the antibody was tested for its activity to prolong allograft survival in seven patients with steroid-refractory allograft rejection. VIT4 inhibited the proliferative response to alloantigens in the mixed lymphocyte reaction (MLR) in a dose-dependent manner. At concentrations of 1 and 10 micrograms/ml VIT4 blocked MLR by 55 +/- 11% and 77 +/- 1%, respectively. Also alloantigen-specific proliferation of in vitro- generated memory T cells was dose-dependently reduced to 23 +/- 1% at a VIT4 concentration of 100 micrograms…

CD4-Positive T-LymphocytesGraft Rejectionmedicine.drug_classImmunologyDose-Response Relationship ImmunologicPilot ProjectsPharmacologyMonoclonal antibodyMiceIn vivoT-Lymphocyte SubsetsmedicineImmunology and AllergyCytotoxic T cellAnimalsHumansCells CulturedImmunosuppression Therapybiologybusiness.industryAntibodies MonoclonalHematologyMixed lymphocyte reactionKidney TransplantationIn vitroCTL*Cell cultureImmunologybiology.proteinPancreas TransplantationAntibodyLymphocyte Culture Test MixedbusinessImmunologic MemoryT-Lymphocytes CytotoxicImmunobiology
researchProduct

Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor O…

2017

Human Cytomegalovirus (CMV) can lead to primary infection or reactivation in CMV-seronegative or -seropositive kidney transplant recipients, respectively. Complications comprise severe end-organ diseases and acute or chronic transplant rejection. Risk for CMV manifestation is stratified according to the CMV-IgG-serostatus, with donor+/recipient- (D+/R-) patients carrying the highest risk for CMV-replication. However, risk factors predisposing for primary infection in CMV-seronegative recipients are still not fully elucidated. Therefore, we monitored D+/R- high-risk patients undergoing kidney transplantation in combination with antiviral prophylaxis for the incidence of CMV-viremia for a med…

Cytomegalovirus InfectionMaleViral DiseasesT-Lymphocyteslcsh:MedicineCytomegalovirusPathology and Laboratory MedicineCell-Mediated ImmunityWhite Blood CellsAnimal CellsMedicine and Health SciencesRenal TransplantationPublic and Occupational Healthlcsh:ScienceImmunity CellularT CellsCold Ischemiavirus diseasesVaccination and ImmunizationTissue DonorsInfectious DiseasesMedical MicrobiologyViral PathogensVirusesCytomegalovirus InfectionsHuman CytomegalovirusFemaleCellular TypesPathogensResearch ArticleHerpesvirusesImmune CellsImmunologySurgical and Invasive Medical ProceduresCytotoxic T cellsSerogroupMicrobiologyUrinary System ProceduresHumansViremiaMicrobial PathogensTransplantationBlood CellsProphylaxislcsh:ROrganismsImmunityBiology and Life SciencesCell BiologyOrgan TransplantationKidney Transplantationlcsh:QPreventive MedicineDNA virusesPLoS ONE
researchProduct

Anti-HLA immunization of patients qualified for lung transplantation – Single center study

2021

For lung transplantation, the presence of donor-specific anti-HLA antibodies (DSA) is an important factor of antibody-mediated rejection (AMR) in its hyperacute, acute or chronic form during long-term follow up. The aim of the study was to assess the allosensitization of Polish patients qualified for a lung transplantation in our center. A retrospective study of 161 potential lung allograft recipients, also of 31 patients transplanted in the Uni-versity Hospital of Gdansk, between June 2018 and December 2020 were performed. 121 potential recipients were thoroughly tested for immunization status before eventual lung transplantation. SAB-testing, PRA-CDC and vPRA assessment, and HLA typing we…

Graft RejectionAnti-HLA sensitizationTransplantationHistocompatibility TestingImmunologyKidney TransplantationTransplant immunologyHLA AntigensIsoantibodiesHumansImmunology and AllergyImmunizationLung TransplantationRetrospective StudiesTransplant Immunology
researchProduct

14th International HLA and Immunogenetics Workshop: Report on the Prospective Chronic Rejection Project

2007

An international collaborative study of 45 transplant centers was undertaken at the 14th International HLA (human leukocyte antigen) and Immunogenetics Workshop to see if HLA antibodies detected posttransplant are predictive of chronic graft failure. With the newly developed assay, MICA (major histocompatibility complex class I-related chain A) antibodies were also measured and their effect analyzed. Total of 5219 sera from patients who were more than 6 months posttransplant with functioning graft were tested for HLA antibodies by enzyme-linked immunosorbent assay, flow cytometry, or Luminex. HLA antibodies were found in 27.2% of kidney patients, 23.6% in the liver, 52.7% in the heart, and …

Graft RejectionMICA antibodyImmunologyHuman leukocyte antigenHistocompatibility TestingImmunogeneticsMajor histocompatibility complexBiochemistryimmunogenetics workshopchronic rejectionHLA AntigensTransplantation ImmunologyImmunogeneticsGeneticsmedicineHumansImmunology and AllergyHLA antibodyKidneyLungbiologybusiness.industryHistocompatibility TestingGraft SurvivalHistocompatibility Antigens Class IPanel reactive antibodymulti-center studyGeneral MedicineKidney Transplantationmedicine.anatomical_structureChronic DiseaseImmunologybiology.proteinHeart TransplantationAntibodybusinessTissue Antigens
researchProduct

Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation

2013

Introduction. Combined liver-kidney transplantation (LKT) is the best therapeutic option for patients with end-stage liver and kidney disease. Objectives. To analyze baseline characteristics and clinical outcome of LKT compared to isolated liver transplantation (LT). Material and methods. The study included 16 LKT performed between 1998 and 2006 and 32 LT matched by age, sex, date and indication for transplantation. Demographic, pretransplant, post-transplant and survival variables were analyzed. Results. As planned by the study design, mean age, distribution by sex and indication for LT were similar between groups. The most common indication for LT was HCV- and/or alcohol-induced cirrhosis…

Graft RejectionMaleTime FactorsCirrhosismedicine.medical_treatmentSpecialties of internal medicineKaplan-Meier EstimateLiver transplantationGastroenterologyKidney transplantationchemistry.chemical_compoundMetabolic complicationsRisk FactorsKidney transplantationOutcomeBacterial InfectionsGeneral MedicineMiddle AgedSurvival RateTreatment OutcomeRC581-951CreatinineHepatocellular carcinomaHypertensionFemaleAdultReoperationmedicine.medical_specialtyAdolescentPostoperative HemorrhageEnd Stage Liver DiseaseRenal DialysisDiabetes mellitusInternal medicinemedicineHumansArterial PressureDialysisAgedCreatinineChi-Square DistributionLiver transplantationHepatologyurogenital systembusiness.industrymedicine.diseaseSurgeryTransplantationchemistryCase-Control StudiesKidney Failure ChronicbusinessBiomarkers
researchProduct